↓ Skip to main content

Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, January 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

policy
1 policy source
patent
3 patents

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
38 Mendeley
Title
Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma
Published in
European Journal of Nuclear Medicine and Molecular Imaging, January 2014
DOI 10.1007/s00259-013-2658-6
Pubmed ID
Authors

Luigi Aloj, Laura D’Ambrosio, Michela Aurilio, Anna Morisco, Ferdinando Frigeri, Corradina Caraco’, Francesca Di Gennaro, Gaetana Capobianco, Leonardo Giovannoni, Hans D. Menssen, Dario Neri, Antonio Pinto, Secondo Lastoria

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 26%
Student > Master 8 21%
Student > Doctoral Student 5 13%
Student > Ph. D. Student 4 11%
Other 2 5%
Other 4 11%
Unknown 5 13%
Readers by discipline Count As %
Medicine and Dentistry 19 50%
Biochemistry, Genetics and Molecular Biology 4 11%
Social Sciences 3 8%
Engineering 2 5%
Chemical Engineering 1 3%
Other 2 5%
Unknown 7 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2022.
All research outputs
#3,463,623
of 23,806,312 outputs
Outputs from European Journal of Nuclear Medicine and Molecular Imaging
#382
of 3,083 outputs
Outputs of similar age
#41,631
of 308,963 outputs
Outputs of similar age from European Journal of Nuclear Medicine and Molecular Imaging
#3
of 31 outputs
Altmetric has tracked 23,806,312 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,083 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 308,963 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.